Core Viewpoint - The A-share market shows a recovery in capital sentiment, with significant gains in various sectors, particularly in steel and photovoltaic industries, driven by a new wave of "de-involution" and capacity reduction initiatives from the government [2]. Group 1: Market Performance - During the week of June 30 to July 4, the Shanghai Composite Index rose by 1.40% to close at 3472.32 points, while the Shenzhen Component Index increased by 1.25% and the ChiNext Index by 1.50% [2]. - The steel and photovoltaic sectors experienced a surge, with photovoltaic glass prices rising over 10% during the week [2]. Group 2: Institutional Research - A total of 158 listed companies disclosed institutional research minutes, with over 70% of the researched stocks achieving positive returns [2]. - Taotao Automotive was the most favored stock by institutions, achieving a remarkable gain of 29.82% during the week [3]. Group 3: Company Highlights - Taotao Automotive, a leader in the North American leisure vehicle market, reported an expected net profit of 310 million to 360 million yuan for the first half of 2025, representing a year-on-year growth of 70.34% to 97.81% [3]. - Shunwang Technology, a core supplier in the esports service sector, discussed its multi-layered computing power service system and AI computing power platform during institutional interactions [4]. - Xinjie Electric, focused on industrial automation, highlighted its advancements in core components for humanoid robots, including hollow cup motors and high-performance optical encoders [5]. - Xiamen Tungsten New Energy is developing new profit growth points, including high-stability lithium supplement materials and a new structure cathode material with improved energy density and performance [6].

以下文章来源于e公司 ，作者证券时报 曾剑 拟并购标的总资产上亿 SEA3公司成立于2016年9月，注册地位于东南亚，注册资本为6333万元。公司股东包括SEA3集团以及6名自然人。上市公司称交易对手与其不存在关 联。 e公司 . e公司，证券时报旗下专注上市公司新媒体产品，立志打造A股上市公司资讯第一平台。提供7x24小时上市公司标准化快讯，针对可能影响上市公司股价 的主题概念、行业事件及时采访二次解读，从投资者需求出发，直播上市公司有价值的活动、会议。 花几块钱就能在东南亚买下一家资产上亿的企业？此事真实发生。 中红医疗（300981）近日披露，其全资子公司中红香港、下属桂林恒保防护国际有限公司（下称"桂林恒保"）签署股份买卖协议和股东协议， 收购东 南亚SEA3公司（下称"SEA3公司"）合计75%股权。 证券时报·e公司记者注意到，SEA3公司75%股权的交易价格仅为6.97元，由中红香港、桂林恒保分别支付4.88元和2.09元。 中红医疗主要从事高品质一次性健康防护用品、医用无菌器械等产品的研发、生产与销售，属于医疗器械行业。 公司产品包括一次性健康防护手套、安 全输注产品（注射器、输液器等）、避孕 ...

傅静涛 A0230516110001 fujt@swsresearch.com 王胜 A0230511060001 wangsheng@swsresearch.com 研究支持 2025 年 07 月 05 日 去产能是慢变量，去产量是快变量 ——申万宏源策略一周回顾展望(25/06/30-25/07/05) 相关研究 韦春泽 A0230524060005 weicz@swsresearch.com 联系人 程翔 (8621)23297818× chengxiang@swsresearch.com 本研究报告仅通过邮件提供给 中庚基金 使用。1 ⚫ 一、反内卷需要区分"去资本开支""去产能""去产量"。 请务必仔细阅读正文之后的各项信息披露与声明 策 略 研 究 证 券 研 究 报 告 一 周 回 顾 展 望 - 证券分析师 ⚫ 反内卷政策加码，唤醒了市场对 2016-17 年的供给侧的记忆。我们认为，2016-17 年供 给侧改革经验，可以拆解成三个核心要素：一是"去产能"，包括淘汰落后产能，也包 括抑制新增资本开支，使得远期产能形成下降。"去产能"的影响是长期的，2022 年之 前以煤炭为代表的周期品盈利 ...

以下文章来源于华夏能源网 ，作者www.hxny.com 华夏能源网 . 能源产业与财经信息服务平台 将投中网设为"星标⭐"，第一时间收获最新推送 等待机会重新起来。 作者丨 田思 作者丨 蒋波 王东 来源丨 华夏能源网 "所有企业都在承受着不可承受之痛，大家都在苦熬。"6月10日，中国机电产品进出口商会副会长 石永红在上海SNEC2025光伏展上说道。 这说出了广大光伏企业的真实状态和心声。 经过 7个季度的持续洗牌，一大批光伏企业倒下了，但产能依旧严重过剩。主要的龙头企业安然无 恙，按照业界调侃的每次寒冬"必死老大"的标准看，调整并没有到位。而那些暂时停产的"死而不 僵"的产能，随时在等待机会重开起来。 与此同时，今年上半年 "抢装潮"带动光伏装机再创新高，仅5月份光伏新增装机就高达92.92GW， 1-5月光伏新增装机198GW，相当于2024年光伏装机的七成。但是，如此强劲的装机还是没能拉起 来价格，光伏各产业链价格还在滑落，寒冬深不见底。 一边是艰难的产能出清，一边是见不到企稳希望的价格，整个光伏行业处在痛苦不堪的 "炼狱"之 中。没有谁会好过，也没有谁知道"炼狱"往下还有几层。大家只能在一点点失血 ...

以下文章来源于大胡子财研社 ，作者湾区区长 大胡子财研社 . 独到的财经观点，深度的金融分析，助你抓住最新财富机会，实现资产稳步增长！ 前两天，中Y财经委员会第六次会议开了。 会议公告公布之后，我看了看，其实最重要的要点是两个： 第一，淘汰落后产能、推动落后产能有序退出 第二，防止无序竞争，整顿内卷。 产能调整、防止内卷，其实这几年一直都在提。 但我看有些人对此的解读是去产能，是又一次供给侧的改革。 我觉得这是纯粹的误读。 因为任何政策出现，都要结合那个时候的经济环境去分析。 很明显，这个时候开会说要淘汰落后产能，目的是 为了下一步刺激内需，而不是去产能。 你不能拿现在的说法去套10年前的去产能和供给侧改革。 因为那个时候的经济环境和现在完全不一样。 而且我非常不认同当下一个很普遍的说法： 产能过剩 就拿太阳能、电动汽车这些所谓的产能过剩产业来说。 全球未来目标如果是在2030年-2050年达成碳达峰，对于 新能源产业的需求是逐年增加的。 很多欠发达地区，比如亚非拉很多发展中国家，他们现在还在不断使用高污染的能源。 这些国家其实也有增加清洁能源的需求，只是这个需求没有被激发，或者说它们还没有相应的基 础设施去 ...

Core Viewpoint - The chemical industry is experiencing a "reverse involution" due to overcapacity, leading to a series of production cuts among companies, including Wankai New Materials, which plans to reduce its PET production capacity by 60,000 tons, accounting for 20% of its total capacity [1][4]. Industry Overview - The domestic PET capacity is projected to reach 20.58 million tons by May 2025, with an operating rate of 88.75%. The recent production cuts involve a total capacity of approximately 3.36 million tons, representing 16.3% of the total capacity, which may lower the operating rate to around 75% [1][3]. - The global demand for PET is expected to grow by approximately 8.2% in 2024, with domestic demand projected at around 8.62 million tons, a year-on-year increase of 14%. Exports are expected to reach about 5.85 million tons, up 28.4% [3][4]. Company Actions - Wankai New Materials reported that the production cuts are a response to supply and demand issues within the industry, with several companies implementing similar measures. Despite a profitable first quarter, the company's profitability remains weak [1][2]. - Other companies, such as China Resources Chemical and Yisheng Petrochemical, have also announced production cuts, with reductions of 20% of their total capacity and a cumulative shutdown of 1 million tons, respectively [4][6]. Financial Performance - The PET industry has seen a significant decline in profitability since 2022 due to rapid capacity expansion and decreased operating rates. Wankai New Materials reported a net loss of 300 million yuan in 2022, while other major players also faced substantial losses [7][8]. - The industry experienced a boom during the pandemic years (2020-2022), with Wankai New Materials' net profit exceeding 1 billion yuan in 2022, but the subsequent capacity surge has led to a challenging market environment [7][8]. Market Dynamics - The current market is characterized by an oversupply situation, with the domestic PET capacity nearing 50% of the global total. The leading companies in the industry hold a significant market share, with the top four companies accounting for over 80% of the total capacity [7]. - Despite production cuts, the market is still under pressure, with analysts indicating that the supply adjustments may provide limited support and are unlikely to fundamentally change the prevailing cost-driven market dynamics [4][8].

Group 1 - The company was established in 2011 through the restructuring of four copper enterprises in Zambia and has become a global leader in vertically integrated copper production [1] - The company has expanded its operations from the Chambishi Copper Mine in Zambia to the Democratic Republic of Congo, forming a "Zambia-Congo" dual-core strategic layout [1] - The company aims to become a world-class mining group by accelerating global resource integration and operational upgrades since its listing on the Hong Kong Stock Exchange in 2012 [1] Group 2 - As of the end of 2024, the company's total ore resources amount to 436 million tons, ranking it among the top tier in the global industry [2] - The company plans to enhance exploration investments, completing over 50,000 meters of drilling and a capital expenditure of $169 million in 2024, a significant increase of 23% year-on-year [2] - From 2020 to 2024, the company's self-produced copper metal volume is expected to increase from 99,000 tons to 159,000 tons, a growth of over 60% [2]

Industry Overview - As of late May 2025, the price of soft foam polyether in China is 0.73 million yuan per ton, a year-on-year decrease of 19.65% [1][9] - The decline in prices is attributed to the fluctuation and decrease in upstream raw material prices, such as propylene oxide, and rapid expansion of domestic production capacity, which reached 9.5 million tons per year by February 2025, with expectations to exceed 11 million tons per year [1][9][10] - The rapid increase in production capacity has led to a significant rise in market supply, while demand growth has not kept pace, resulting in an imbalance between supply and demand [1][9] Industry Development History - The soft foam polyether industry in China has undergone four main stages: the initial stage (1989-1993), rapid development (1993-1999), technological innovation (2000-2010), and green development (2010-present) [3][4][5] - The initial stage saw the establishment of the first large-scale polyether production facility in Tianjin, marking the beginning of industrial production [3] - The rapid development phase was characterized by the introduction of new products and significant increases in production capacity, with a focus on high-end applications [3] - The technological innovation phase involved advancements in production technology and increased government support for new materials [4] - The current green development phase emphasizes technological breakthroughs in catalysts and sustainable practices due to stricter environmental regulations [5] Industry Supply Chain - The upstream of the soft foam polyether industry includes basic chemical raw materials (propylene oxide, ethylene oxide), initiators (glycerol, propylene glycol), catalysts, and production equipment [7] - The midstream involves the manufacturing of soft foam polyether, while the downstream applications span across furniture, automotive, footwear, construction insulation, waterproof coatings, and packaging materials [7] Current Industry Status - The total production capacity of soft foam polyether in China was 9.413 million tons in 2024, with a year-on-year growth of 2.34% [10] - Major companies like Wanhua Chemical, Longhua New Materials, and Changhua Chemical dominate the market, leveraging their technological and scale advantages [10][14] - The consumption of soft foam polyether in the first four months of 2025 reached 122.56 thousand tons, a year-on-year increase of 7.15%, driven by recovery in downstream sectors like furniture and automotive [12] Key Companies' Performance - Wanhua Chemical Group, established in 1978, is a significant player in the global polyether market, focusing on technological innovation and expanding its production capacity [18] - Longhua New Materials, founded in 2011, has become a leading company in the domestic soft foam polyether industry, achieving a market share of 30% in polymer polyols [16] - In 2024, Longhua New Materials reported a revenue of 5.624 billion yuan, a year-on-year increase of 12.01% [16] Industry Development Trends - The industry is expected to see optimization of production capacity and increased concentration, with leading companies like Wanhua Chemical and Longhua New Materials driving capacity consolidation [20] - There is a strong emphasis on technological innovation and green transformation, with companies adopting low-VOC formulations and developing bio-based polyethers [21][22] - Downstream demand is diversifying, with traditional markets slowing while new sectors like automotive and cold chain logistics are emerging as key growth areas [23]

点击上图▲立即收听 " 近几年 ' 内卷式 ' 竞争的出现，并非是企业、雇员变得 ' 急功近利 ' 所致，其背后有深刻的宏观经济背景，受经济周期变化、体制机制问题和技术发展规律综合影响。 文 / 巴九灵（微信公众号：吴晓波频道） 一股"刀刃向内"的改革正在一些重点行业展开。 汽车行业在这轮行动中最出圈，轰轰烈烈的60天账期革命备受关注，与此同时，近日，全国工商联汽车经销商商会又向各大汽车生产厂家提出缩 短返利兑现账期、简化返利政策、取消复杂限制条件等呼吁，打响了"反内卷"第二枪。 据路透社报道，中国新能源一家头部企业近期在多家工厂取消夜班、将部分产线产能削减至少1/3，并推迟新增产线计划。 还有"二师兄"。近期， 多家头部猪企接相关部门要求，去产能、二育调控、头部企业带头稳价格，集团场暂停能繁母猪扩产，出栏体重也需要控 制在120公斤左右。 光伏行业在主动踩刹车。自7月起，国内头部光伏玻璃企业计划集体减产30％，预计供应量将由此前的约64GW降至约45GW。 水泥行业则在展开自查。中国水泥协会发布文件，要求各会员企业对照备案产能与实际产能差异，依法依规按备案日产能和年产能组织生产。 " 7月的第一天， 中央财 ...

Summary of Key Points Core Viewpoint The company, Kailaiying Pharmaceutical Group (Tianjin) Co., Ltd., is undergoing changes in the use of raised funds, including new investment projects, adjustments in investment amounts, and delays in project timelines, to enhance operational efficiency and align with market opportunities. Group 1: Fundraising Overview - The company raised a total of RMB 2,277,875,164.30 from a non-public stock issuance, with a net amount of RMB 2,274,960,656.06 after deducting issuance costs [1][2] - The funds are stored in a dedicated account, regulated by a tripartite agreement among the company, the sponsor, and the bank [2] Group 2: Fund Usage Status - As of June 30, 2025, the company has allocated funds to various projects, including the expansion of its life sciences platform and the construction of a biopharmaceutical R&D base [3][4] - The total investment for the projects is RMB 228,070.62 million, with cumulative investments of RMB 163,909.18 million [4] Group 3: Changes in Fund Usage - The company has proposed to change the use of funds for the "Taixing Project" and redirect remaining funds to new projects, including a chemical macromolecule project and a high-end formulation project [5][6] - The investment amount for the Taixing Project will be reduced by RMB 400 million, with the remaining funds allocated to new projects [6][11] Group 4: New Investment Projects - A new project, the "Chemical Macromolecule Integration Project," will receive RMB 47,367.72 million from the remaining funds, with a total investment of RMB 50,800.00 million [11][12] - The project aims to enhance the company's capacity in the CDMO field and is expected to take 48 months to complete [12][14] Group 5: Financial Performance - The company's total assets as of December 31, 2024, were RMB 3,073,514,644.17, with total liabilities of RMB 2,080,120,300.01 and net assets of RMB 993,394,344.16 [13] - The company reported a revenue of RMB 1,597,172,881.12 and a net profit of RMB 52,163,151.56 for the same period [13] Group 6: Strategic Implications - The changes in fund usage are aligned with the company's long-term strategic planning and are expected to improve operational efficiency and competitiveness [19][20] - The company aims to leverage market trends and enhance its capabilities in innovative drug development, particularly in the chemical macromolecule sector [15][16]